1. Home
  2. NYXH vs QSI Comparison

NYXH vs QSI Comparison

Compare NYXH & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nyxoah SA

NYXH

Nyxoah SA

SELL

Current Price

$1.12

Market Cap

137.5M

Sector

Health Care

ML Signal

SELL

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

SELL

Current Price

$1.11

Market Cap

165.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NYXH
QSI
Founded
2009
2013
Country
Belgium
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.5M
165.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
NYXH
QSI
Price
$1.12
$1.11
Analyst Decision
Buy
Buy
Analyst Count
4
3
Target Price
★ $4.20
$2.30
AVG Volume (30 Days)
148.1K
★ 8.4M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.17
EPS
★ N/A
N/A
Revenue
N/A
★ $2,436,000.00
Revenue This Year
$275.91
N/A
Revenue Next Year
$93.27
$406.32
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.19
$0.69
52 Week High
$6.00
$2.73

Technical Indicators

Market Signals
Indicator
NYXH
QSI
Relative Strength Index (RSI) 31.61 50.63
Support Level N/A $0.81
Resistance Level $1.69 $1.32
Average True Range (ATR) 0.06 0.19
MACD -0.02 0.00
Stochastic Oscillator 2.50 36.42

Price Performance

Historical Comparison
NYXH
QSI

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.

Share on Social Networks: